Earnings on October 12, 2026

Before Market Open

Stock	Est. Rev	Est. EPS	Report
No companies reporting.

After Market Close

Stock	Est. Rev	Est. EPS	Report
Nurix Therapeutics, Inc.NRIX	$24.3M	-$0.60	Q3